How Common is Post-Cholecystectomy Syndrome?
Post-cholecystectomy syndrome occurs in approximately 3-34% of patients following gallbladder removal, with the most rigorous recent meta-analysis reporting an overall incidence of 3.21%. 1
Incidence Varies by Study Design and Definition
The reported frequency of post-cholecystectomy syndrome (PCS) shows considerable variation depending on how it's defined and measured:
Meta-analysis data (2026): The pooled incidence from 9 studies involving 2,948 patients was 3.21% (95% CI: 2.27-4.55%) 1. This represents the most methodologically rigorous estimate available.
Single-center prospective studies: A UK tertiary center found 34% of patients reported ongoing symptoms consistent with PCS within 6 months of surgery 2, while a Saudi Arabian private tertiary center reported 23.3% 3.
Italian surgical literature: Estimates PCS at 10-15% of all cholecystectomies 4.
Why the Wide Range?
The substantial variation in reported incidence stems from several factors:
Definitional inconsistency: There is no universally accepted diagnostic criteria for PCS. Some studies count any persistent symptom, while others require specific biliary-related complications or need for intervention 5.
Time of assessment: The 2026 meta-analysis noted that 71.8% of PCS cases were "incident" (new onset) rather than persistent from pre-operative symptoms 3. Most cases manifest within the first year post-operatively 3.
Patient selection: Studies including emergency cholecystectomies or complicated cases report higher rates than those limited to elective, uncomplicated procedures.
Clinical Context Matters
Preoperative complications are the strongest predictor: Patients with pre-existing symptoms before cholecystectomy have dramatically higher PCS risk (OR = 26.91,95% CI: 7.87-92.03) 1. This suggests that many "PCS" cases may represent continuation of the original pathology rather than a true surgical complication.
Most patients still benefit: Despite PCS symptoms, 88% of affected patients reported improved quality of life post-surgery 2, indicating that symptom persistence doesn't necessarily equate to surgical failure.
Common Pitfalls in Interpretation
Be cautious when comparing PCS rates across studies—the term encompasses everything from mild dyspepsia to serious biliary complications requiring reoperation. The 3.21% figure from the 2026 meta-analysis 1 likely represents clinically significant PCS, while the 34% figure 2 captures any persistent symptom regardless of severity or clinical impact.
For practical clinical counseling: Tell patients there's approximately a 3-5% risk of clinically significant post-cholecystectomy syndrome requiring further investigation or treatment, with a broader 10-25% chance of some persistent symptoms that typically don't significantly impact quality of life.